Full-Time

Principal Scientist

Updated on 4/25/2024

Cerevel Therapeutics

Cerevel Therapeutics

201-500 employees

Develops therapies for central nervous system disorders

Biotechnology

Senior, Expert

Cambridge, MA, USA

Requirements
  • Significant experience in small molecule process development
  • Hands on crystallization experience
  • Exposure to technology transfer and process development
  • Familiarity with the preparation of process, analytical, and characterization reports
  • Management of on-time API deliveries
  • Familiarity with potential genotoxic impurity assessments
  • Working knowledge of core analytical techniques (HPLC, GC, LCMS, NMRS)
  • Sound understanding of cGMPs, ICH guidelines, applicable regulatory guidance
Responsibilities
  • Drive design and execution of multi-step organic syntheses of small molecule drug candidates
  • Provide input and guidance to the planning, execution, and oversight of technology transfer and validation of processes
  • Independently apply sound scientific principles and creative thinking to ensure the selection of innovative and robust synthetic routes
  • Leverage literature review and ongoing awareness of state of the art in designing and executing new routes
  • Collaborate with Cerevel’s Global Quality Assurance function on investigations or events and resolve them in a timely manner
  • Contribute to the completion of reports necessary to support regulatory strategies and filings
  • Present technical data to cross functional teams and senior management
  • Collaborate with internal groups such as Analytical Development, Formulation Development, Supply Chain, Global Quality Assurance, and Regulatory CMC to advance Cerevel’s pre-clinical and clinical candidates

Cerevel Therapeutics is dedicated to developing experimental neuroscience therapies for central nervous system disorders, focusing on understanding neurocircuitry deficits to unlock new treatment opportunities.

Company Stage

IPO

Total Funding

$1.8B

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

7%

1 year growth

13%

2 year growth

55%